What Next: TBD | Tech, power, and the future
Technology
The diabetes medication Ozempic has exploded in popularity, particularly amongst those in Hollywood looking to lose a few extra pounds. But a silver bullet for weight loss leads to a number of questions: Is “buying weight loss” via injection somehow worse than diet and exercise? Are so many people buying and using this drug that people who need it for its intended purpose are missing out? What happened to body positivity?
Guest: Matthew Schneier, feature writer for New York Magazine.
Host: Lizzie O’Leary
If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Oversight Board to Facebook: Nice Try
Tim Apple vs. Mark Facebook
What's Causing the Tesla Crashes?
Seduced by Substack
The Rise of the Therapy Apps
Introducing: ICYMI
The Fight Over Vaccine Passports
The AstraZeneca Saga
Hate, Lies, and AI
Does Google Actually Want to Hire Black Engineers?
The Failing Lifeline for Low-Income Americans
Australia’s Kinda-Sorta Win Over Big Tech
Why Texas Went Dark
How Clubhouse Cracked China’s Firewall
India Turns Off the Internet
Inside the Subreddit That Blew Up GameStop
Why the Vaccine Websites Suck
Where the Far Right Is Meeting Now
Deplatforming the President
Was This Google Ethicist Fired for Doing Her Job?
Create your
podcast in
minutes
It is Free
Slow Burn
Slate Debates
What Next | Daily News and Analysis
Decoder Ring
Amicus With Dahlia Lithwick | Law, justice, and the courts